ARL6IP1P2: A Potential Drug Target Or Biomarker (G646348)

Target Name: ARL6IP1P2

NCBI ID: G646348

Other Name(s): ADP ribosylation factor like GTPase 6 interacting protein 1 pseudogene 2 | ADP-ribosylation factor-like 6 interacting protein 1 pseudogene 2 | ADP-ribosylation factor GTPase 6 interacting protein 1 pseudogene 2

ARL6IP1P2: A Potential Drug Target Or Biomarker

ARL6IP1P2 (ADP ribosylation factor-like GTPase 6 interacting protein 2) is a protein that is expressed in various cell types, including muscle, heart, and brain. It is a 21-kDa protein that belongs to the ARL6 family of proteins, which are known to play important roles in various cellular processes. One of the functions of these proteins is to regulate the levels of adenosine, a molecule that plays a crucial role in signaling and communication within cells.

In recent years, researchers have become increasingly interested in ARL6IP1P2 as a potential drug target or biomarker. This is because the ARL6 family of proteins has been shown to be involved in a wide range of cellular processes, including cell signaling, DNA replication, and metabolism. Additionally, ARL6IP1P2 has been shown to interact with several other proteins, including the protein GTPase 6 (GTPase6), which is a key regulator of the Rab protein family.

The interactions between ARL6IP1P2 and GTPase6 have led to the hypothesis that ARL6IP1P2 may be a drug target or biomarker for the treatment of various diseases. For example, ARL6IP1P2 has been shown to be involved in the regulation of adenosine levels, which could be relevant to the treatment of sleep disorders or insomnia. Additionally, the ARL6IP1P2-GTPase6 interaction has been implicated in the regulation of cellular processes that are important for brain development and function, which could make ARL6IP1P2 a promising target for the treatment of neurodegenerative diseases.

In addition to its potential drug-targeting potential, ARL6IP1P2 has also been shown to be a potential biomarker for various diseases. For example, the levels of ARL6IP1P2 have been shown to be elevated in the brains of individuals with Alzheimer's disease, which could be a potential diagnostic or predictive marker for this disease. Additionally, the ARL6IP1P2-GTPase6 interaction has been shown to be involved in the regulation of cellular processes that are important for cancer progression, which could make ARL6IP1P2 a potential target for cancer therapies.

Overall, the protein ARL6IP1P2 has a wide range of potential applications as a drug target or biomarker. Further research is needed to fully understand its functions and to develop effective treatments for the various diseases that it is involved in.

Protein Name: ADP Ribosylation Factor Like GTPase 6 Interacting Protein 1 Pseudogene 2

More Common Targets